Inoviem Scientific appoints Michel Hubert as a new member of its supervisory board
Strasbourg – August 2017
Inoviem Scientific is happy to announce that Michel HUBERT, president and founder of NHBP Consulting has joined its supervisory board. With 25 years of experience in business development by Abbott Laboratories, Solvay Pharmaceuticals, Novartis, Transgene, Laboratoires Fournier and Rhône-Poulenc (now Sanofi), Inoviem hopes to benefit from his outstanding track record of deal making. To cope with its ambitious mid-term strategy, Inoviem wanted to be advised by Michel HUBERT who was instrumental in deals such as Abbott Fournier Tricor license agreement and related fenofibrate novel formulation deals, Roche Transgene HPV vaccine licensing agreement, Novartis MGH MIT Huntington Disease R&D agreement. Thanks to this impressive experience and broad network, Inoviem undertakes to boost its activity.